Grassley
Direct
I
spoke
with
Tom
Williamson
of
KCII
in
Albia
and
Gordon
Wolf
of
the
Denison
Bulletin
&
Review
about
the
Senate
health
care
replacement
plan,
the
Foreign
Agents
Registration
Act,
tax
reform
and
EPA’s
proposed
volume
obligations
under
the
Renewable
Fuel
Standard
program.
Q&A:
Spending
Oversight
Q.
What
drives
your
relentless
grip
on
federal
purse
strings?
Q.
Is
the
Pentagon
making
strides
to
fix
its
bookkeeping
flaws?
Q.
How
can
tax
dollars
lost
to
fraud
be
recovered?
Quick
Links
I led
a
Judiciary
Committee hearing
on
the
president’s
nominee
to
be
FBI
director,
Christopher
Wray.
Mr.
Wray,
a
widely
respected
lawyer
and
former
assistant
attorney
general,
answered
questions
and
demonstrated
his
strong
qualifications
for
this
important
job.
Since
the
FBI
is
our
country’s
top
law
enforcement
agency,
I
hope
to
process
this
nominee
quickly
so
he
can
be
considered
by
the
full
Senate
as
soon
as
next
week.
A
new
watchdog report shows
opioids
are
commonly
prescribed
to
Medicare
beneficiaries,
and
some
of
those
beneficiaries
are
at
serious
risk
of
dangerous
results.
A
bipartisan
bill
I
introduced
would
shine
light
into
drug
company
payments
to
medical
practitioners
who
prescribe
opioids
but
fly
under
the
radar
on
oversight.
Maintaining
foot
and
ankle
mobility
helps
people
exercise,
which
prevents
other
health-related
problems.
I
introduced
a
bipartisan
bill
to improve patient
access
to
podiatrists
in
Medicaid
and
improve
care
for
patients
with
diabetes
who
need
therapeutic
shoes
via
Medicare.
I
urged
the
Centers
for
Medicare
and
Medicaid
Services
to recover
as
much
as
possible
of
more
than
$729.4
million
in
reported
inappropriate
Obama-era
electronic
health
records
incentive
payments. The
agency
should
recover
as
much
as
possible
of
the
misspent
money
and
if
it
can’t,
let
Congress
know
why
not.
Post
of
the
Week
|